LP34567-5
Repaglinide
Active
Description
Repaglinide (Prandin in the U.S., GlucoNorm in Canada, NovoNorm elsewhere) is used for the treatment of type II diabetes. It lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion. The half life of Repaglinide is 1 hour. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Repaglinide
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2004-09-03
- Construct for LOINC Short Name
- Repaglinide
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP34567-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP34567-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 瑞格列奈 |
| fr-CA | French (Canada) | Répaglinide |
| et-EE | Estonian (Estonia) | Repagliniid |
| es-ES | Spanish (Spain) | Repaglinida |
| it-IT | Italian (Italy) | Repaglinide |
| tr-TR | Turkish (Turkey) | Repaglinid |
| ru-RU | Russian (Russian Federation) | Репаглинид |
| nl-NL | Dutch (Netherlands) | repaglinide |
| fr-BE | French (Belgium) | Répaglinide |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright